Cargando…
Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-β-Mediated Deregulation of Estradiol
Alzheimer's disease (AD) is a conformational disease that is characterized by amyloid-β (Aβ) deposition in the brain. Aβ exerts its toxicity in part by receptor-mediated interactions that cause down-stream protein misfolding and aggregation, as well as mitochondrial dysfunction. Recent reports...
Autores principales: | Lim, Yun-An, Grimm, Amandine, Giese, Maria, Mensah-Nyagan, Ayikoe Guy, Villafranca, J. Ernest, Ittner, Lars M., Eckert, Anne, Götz, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236223/ https://www.ncbi.nlm.nih.gov/pubmed/22174920 http://dx.doi.org/10.1371/journal.pone.0028887 |
Ejemplares similares
-
Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein
por: Grimm, Amandine, et al.
Publicado: (2015) -
Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
por: Grimm, Amandine, et al.
Publicado: (2012) -
Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β
por: Schonrock, Nicole, et al.
Publicado: (2010) -
TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis
por: Lejri, Imane, et al.
Publicado: (2019) -
Mr Damien Abad
por: Gadmer, Jean-Claude Robert
Publicado: (2015)